We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Tempus AI endeavors to unlock the true power of precision medicine by creating Intelligent Diagnostics through the practical application of artificial intelligence in healthcare. Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal. ... Tempus AI endeavors to unlock the true power of precision medicine by creating Intelligent Diagnostics through the practical application of artificial intelligence in healthcare. Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal. To accomplish this, we built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Our proprietary technology has allowed us to amass what we consider to be one of the largest libraries of clinical and molecular oncology data in the world. We have launched a suite of different products derived from our Platform, which have gained significant traction over the past five years. To date, our offerings have been used by approximately 95% of the largest public pharmaceutical companies. Show more
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, will participate in the Piper Sandler 36th Annual Healthcare...
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the collaboration with Flatiron Health, a leading...
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced publication of its study, “Actionable structural...
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced nine abstracts were accepted for presentation at the...
IPS test validation study data will be unveiled at the 2024 SITC Annual Meeting Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 10.51 | 19.9809885932 | 52.6 | 64.01 | 48.2601 | 1405056 | 55.24339346 | CS |
4 | 19.43 | 44.4826007326 | 43.68 | 79.4899 | 39.34 | 1533939 | 57.37105516 | CS |
12 | 4.06 | 6.87552921253 | 59.05 | 79.4899 | 39.34 | 1172272 | 53.22704199 | CS |
26 | 23.11 | 57.775 | 40 | 79.4899 | 22.89 | 1227519 | 47.46844351 | CS |
52 | 23.11 | 57.775 | 40 | 79.4899 | 22.89 | 1227519 | 47.46844351 | CS |
156 | 23.11 | 57.775 | 40 | 79.4899 | 22.89 | 1227519 | 47.46844351 | CS |
260 | 23.11 | 57.775 | 40 | 79.4899 | 22.89 | 1227519 | 47.46844351 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions